| 1 |
Combined inhibition of EGFR and c-ABL suppresses the growth of fulvestrant-resistant breast cancer cells through miR-375-autophagy axis
Liu LM, Shen WF, Zhu ZH, Lin JX, Fang QX, Ruan YP, Zhao HJ
Biochemical and Biophysical Research Communications, 498(3), 559, 2018 |
| 2 |
Downregulation of TXNIP leads to high proliferative activity and estrogen-dependent cell growth in breast cancer
Park JW, Lee SH, Woo GH, Kwon HJ, Kim DY
Biochemical and Biophysical Research Communications, 498(3), 566, 2018 |
| 3 |
Lamin A overexpression promotes osteoblast differentiation and calcification in the MC3T3-E1 preosteoblastic cell line
Tsukune N, Naito M, Kubota T, Ozawa Y, Nagao M, Ohashi A, Sato S, Takahashi T
Biochemical and Biophysical Research Communications, 488(4), 664, 2017 |
| 4 |
Fulvestrant radiosensitizes human estrogen receptor-positive breast cancer cells
Wang J, Yang QF, Haffty BG, Li XY, Moran MS
Biochemical and Biophysical Research Communications, 431(2), 146, 2013 |
| 5 |
A DNA Repair BRCA1 Estrogen Receptor and Targeted Therapy in Breast Cancer
Ratanaphan A
International Journal of Molecular Sciences, 13(11), 14898, 2012 |
| 6 |
Electrochemical determination of anticancer drug fulvestrant at dsDNA modified pencil graphite electrode
Dogan-Topal B, Ozkan SA
Electrochimica Acta, 56(12), 4433, 2011 |
| 7 |
Anodic behaviour of fulvestrant and its voltammetric determination in pharmaceuticals and human serum on highly boron-doped diamond electrode using differential pulse adsorptive stripping voltammetry
Dogan-Topal B, Kul D, Ozkan SA, Uslu B
Journal of Applied Electrochemistry, 41(11), 1253, 2011 |
